PT - JOURNAL ARTICLE AU - Al Haboob, Ali A. TI - Miller Fischer and posterior reversible encephalopathy syndromes post COVID-19 infection AID - 10.17712/nsj.2021.3.20210002 DP - 2021 Jul 01 TA - Neurosciences Journal PG - 295--299 VI - 26 IP - 3 4099 - http://nsj.org.sa/content/26/3/295.short 4100 - http://nsj.org.sa/content/26/3/295.full SO - Neurosciences (Riyadh)2021 Jul 01; 26 AB - COVID-19 infection displays heterogeneity of clinical manifestations in symptomatic and asymptomatic patients. We report on a child with Miller Fischer syndrome (MFS) and posterior reversible encephalopathy syndrome (PRES) post-COVID-19 infection. An 11-year-old boy presented with vomiting, headache, blurred vision, dysarthria, dysphagia, respiratory failure, muscle weakness, and unsteadiness. He had been exposed to COVID-19 through an asymptomatic elder brother two months prior to his illness. The MRI brain showed findings consistent with PRES and the diagnosis with Miller Fischer variant of the Guillain-Barré syndrome was made. A cerebrospinal fluid analysis revealed cytoalbuminous dissociation, and a nerve conduction velocity study conclusively showed polyneuropathy. A fluoroscopy of the diaphragms found that there was limited movement in both. Although children seem to be less affected by COVID-19 infection, this report highlights on an important neurological complications that can develop in children and its presence should be taken into consideration when diagnosing different forms of Guillain-Barré.